Menu Back toSession 1 Track 1: Improving Clinical Trials Using Digital Tools: Opportunities Ready for Prime Time

Digital Technology in Clinical Trials

This event is now offered in a new entirely virtual format.


Session 1 Track 1: Improving Clinical Trials Using Digital Tools: Opportunities Ready for Prime Time

Session Chair(s)

Jennifer  Goldsack, MA, MBA, MS

Jennifer Goldsack, MA, MBA, MS

  • Executive Director
  • Digital Medicine Society (DiMe), United States
Digital tools offer the potential to improve the efficiency, probability of success, and patient centricity of clinical trials. In addition, opportunities for digital innovation exist throughout the clinical trials lifecycle. Consequently, sponsors today face a proliferation of digital products being touted as solutions. This session aims to first help identify challenges in our industry well suited to digital solutions, then support the evaluation and implementation of solutions available today.
Learning Objective :

At the conclusion of this session, participants should be able to:

  • Identify challenges in clinical trials that are particularly well suited to digital solutions
  • Discuss digital tools currently deployed in clinical trials, characteristics of these tools, and the value they offer patients and sponsors
  • Describe the impact of digital tools on trial design and conduct, including decentralized and hybrid clinical trials

Speaker(s)

Bray  Patrick-Lake, MS

Speaker

Bray Patrick-Lake, MS

  • Director, Strategic Partnerships
  • Evidation Health, Inc., United States
Daniel Rollings Karlin, DrMed, MA, FAPA

Speaker

Daniel Rollings Karlin, DrMed, MA, FAPA

  • Chief Executive Officer
  • Healthmode, Inc., United States
Isaac  Rodriguez-Chavez, MHS, PhD, MS

Decentralized Clinical Trials (DCTs) Using Digital Health Technologies (DHTs)

Isaac Rodriguez-Chavez, MHS, PhD, MS

  • Senior Vice President, Scientific and Clinical Affairs, Global COE
  • PRA Health Sciences, United States